Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118673992 | 11867399 | 2 | F | 200003 | 20160826 | 20151224 | 20160826 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-10583250 | BRISTOL MYERS SQUIBB | 4.63 | YR | M | Y | 3.47000 | KG | 20160826 | OT | US | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118673992 | 11867399 | 1 | PS | ZERIT | STAVUDINE | 1 | Transplacental | UNK | U | 20412 | CAPSULE, HARD | ||||||||
| 118673992 | 11867399 | 2 | SS | ZERIT | STAVUDINE | 1 | Oral | UNK | U | 0 | ORAL SOLUTION | ||||||||
| 118673992 | 11867399 | 3 | SS | VIDEX | DIDANOSINE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118673992 | 11867399 | 4 | SS | VIDEX | DIDANOSINE | 1 | Oral | UNK | U | 0 | POWDER FOR ORAL SOLUTION | ||||||||
| 118673992 | 11867399 | 5 | SS | SUSTIVA | EFAVIRENZ | 1 | Transplacental | UNK | U | 0 | CAPSULE | ||||||||
| 118673992 | 11867399 | 6 | SS | VIRAMUNE | NEVIRAPINE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118673992 | 11867399 | 7 | SS | VIRAMUNE | NEVIRAPINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 118673992 | 11867399 | 8 | SS | COMBIVIR | LAMIVUDINEIDOVUDINE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118673992 | 11867399 | 9 | SS | NORVIR | RITONAVIR | 1 | Transplacental | UNK | Y | 0 | |||||||||
| 118673992 | 11867399 | 10 | SS | RETROVIR | ZIDOVUDINE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118673992 | 11867399 | 11 | SS | INVIRASE | SAQUINAVIR MESYLATE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118673992 | 11867399 | 12 | SS | CRIXIVAN | INDINAVIR SULFATE | 1 | Transplacental | UNK | Y | 0 | |||||||||
| 118673992 | 11867399 | 13 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118673992 | 11867399 | 14 | C | GYNO PEVARYL | ECONAZOLE NITRATE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118673992 | 11867399 | 15 | C | LOXEN | NICARDIPINE HYDROCHLORIDE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118673992 | 11867399 | 16 | C | SALBUTAMOL | ALBUTEROL | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118673992 | 11867399 | 17 | C | SPASFON | PHLOROGLUCINOL | 1 | Transplacental | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118673992 | 11867399 | 1 | Product used for unknown indication |
| 118673992 | 11867399 | 2 | HIV infection |
| 118673992 | 11867399 | 3 | Product used for unknown indication |
| 118673992 | 11867399 | 4 | HIV infection |
| 118673992 | 11867399 | 5 | Product used for unknown indication |
| 118673992 | 11867399 | 6 | Product used for unknown indication |
| 118673992 | 11867399 | 7 | HIV infection |
| 118673992 | 11867399 | 8 | Product used for unknown indication |
| 118673992 | 11867399 | 9 | Product used for unknown indication |
| 118673992 | 11867399 | 10 | Product used for unknown indication |
| 118673992 | 11867399 | 11 | Product used for unknown indication |
| 118673992 | 11867399 | 12 | Product used for unknown indication |
| 118673992 | 11867399 | 13 | Product used for unknown indication |
| 118673992 | 11867399 | 14 | Product used for unknown indication |
| 118673992 | 11867399 | 15 | Product used for unknown indication |
| 118673992 | 11867399 | 16 | Product used for unknown indication |
| 118673992 | 11867399 | 17 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118673992 | 11867399 | HO |
| 118673992 | 11867399 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118673992 | 11867399 | Abnormal behaviour | |
| 118673992 | 11867399 | Aspartate aminotransferase increased | |
| 118673992 | 11867399 | Blood creatine phosphokinase increased | |
| 118673992 | 11867399 | Blood lactate dehydrogenase increased | |
| 118673992 | 11867399 | Cardiovascular disorder | |
| 118673992 | 11867399 | Depression | |
| 118673992 | 11867399 | Electroencephalogram abnormal | |
| 118673992 | 11867399 | Foetal exposure during pregnancy | |
| 118673992 | 11867399 | Gastrointestinal disorder | |
| 118673992 | 11867399 | Gastrointestinal haemorrhage | |
| 118673992 | 11867399 | Haematochezia | |
| 118673992 | 11867399 | Hepatic enzyme increased | |
| 118673992 | 11867399 | Hypertriglyceridaemia | |
| 118673992 | 11867399 | Lipase increased | |
| 118673992 | 11867399 | Microcytosis | |
| 118673992 | 11867399 | Neutropenia | |
| 118673992 | 11867399 | Pyelonephritis | |
| 118673992 | 11867399 | Segmented hyalinising vasculitis | |
| 118673992 | 11867399 | Speech disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118673992 | 11867399 | 5 | 199906 | 0 | ||
| 118673992 | 11867399 | 8 | 199906 | 0 | ||
| 118673992 | 11867399 | 12 | 199906 | 0 |